Praveena T, Le Nours J
Front Immunol. 2024; 15:1479382.
PMID: 39669569
PMC: 11635198.
DOI: 10.3389/fimmu.2024.1479382.
Hao T, Mi T, Chu Q, Ma W, Cheng X, Zang Y
ACS Med Chem Lett. 2024; 15(7):1102-1108.
PMID: 39015265
PMC: 11247626.
DOI: 10.1021/acsmedchemlett.4c00199.
Chen Y, Hung J, Jan F, Su Y, Hwu J, Yu A
Int J Mol Sci. 2022; 23(21).
PMID: 36362187
PMC: 9659121.
DOI: 10.3390/ijms232113403.
Borras-Tuduri R, Alcaide A, Aspeslag S, Usero L, Serra C, Roura-Mir C
ChemMedChem. 2021; 16(16):2491-2496.
PMID: 33821540
PMC: 8453509.
DOI: 10.1002/cmdc.202000992.
Pifferi C, Fuentes R, Fernandez-Tejada A
Nat Rev Chem. 2021; 5(3):197-216.
PMID: 33521324
PMC: 7829660.
DOI: 10.1038/s41570-020-00244-3.
Synthesis and structure-activity relationships of cerebroside analogues as substrates of cerebroside sulphotransferase and discovery of a competitive inhibitor.
Li W, Guillaume J, Baqi Y, Wachsmann I, Gieselmann V, Van Calenbergh S
J Enzyme Inhib Med Chem. 2020; 35(1):1503-1512.
PMID: 32657203
PMC: 7470129.
DOI: 10.1080/14756366.2020.1791841.
Enhancing Neuroblastoma Immunotherapies by Engaging iNKT and NK Cells.
McNerney K, Karageorgos S, Hogarty M, Bassiri H
Front Immunol. 2020; 11:873.
PMID: 32457760
PMC: 7225357.
DOI: 10.3389/fimmu.2020.00873.
Development of α-GalCer Analogues with an α-Fluorocarbonyl Moiety as Th2-Selective Ligands of CD1d.
Kim H, Song H, Park J, Lee D, Park S
ACS Med Chem Lett. 2019; 10(5):773-779.
PMID: 31097998
PMC: 6511957.
DOI: 10.1021/acsmedchemlett.9b00026.
Synthesis and biological activities of C-glycosides of KRN 7000 with novel ceramide residues.
Altiti A, Ma X, Zhang L, Ban Y, Franck R, Mootoo D
Carbohydr Res. 2017; 443-444:73-77.
PMID: 28365448
PMC: 5499692.
DOI: 10.1016/j.carres.2017.03.005.
Antigen specificity of invariant natural killer T-cells.
Birkholz A, Kronenberg M
Biomed J. 2016; 38(6):470-83.
PMID: 27013447
PMC: 6138764.
DOI: 10.1016/j.bj.2016.01.003.
Colocalization of a CD1d-Binding Glycolipid with a Radiation-Attenuated Sporozoite Vaccine in Lymph Node-Resident Dendritic Cells for a Robust Adjuvant Effect.
Li X, Kawamura A, Andrews C, Miller J, Wu D, Tsao T
J Immunol. 2015; 195(6):2710-21.
PMID: 26254338
PMC: 4561196.
DOI: 10.4049/jimmunol.1403017.
Design and Evaluation of ω-Hydroxy Fatty Acids Containing α-GalCer Analogues for CD1d-Mediated NKT Cell Activation.
Lim C, Kim J, Baek D, Lee J, Cho M, Lee Y
ACS Med Chem Lett. 2014; 5(4):331-5.
PMID: 24900836
PMC: 4027640.
DOI: 10.1021/ml400517b.
Heteroaromatic Moieties in the Sphingosine Backbone of α-Galactosylceramides for Noncovalent Interactions with CD1d.
Kim Y, Kim J, Oh K, Lee D, Park S
ACS Med Chem Lett. 2014; 3(2):151-4.
PMID: 24900444
PMC: 4025800.
DOI: 10.1021/ml200278u.
Anti-inflammatory effects of α-galactosylceramide analogs in activated microglia: involvement of the p38 MAPK signaling pathway.
Jeong Y, Kim Y, Song H, Chung Y, Park S, Kim H
PLoS One. 2014; 9(2):e87030.
PMID: 24523867
PMC: 3921125.
DOI: 10.1371/journal.pone.0087030.
The versatility of the αβ T-cell antigen receptor.
Bhati M, Cole D, McCluskey J, Sewell A, Rossjohn J
Protein Sci. 2013; 23(3):260-72.
PMID: 24375592
PMC: 3945834.
DOI: 10.1002/pro.2412.
Stimulation of natural killer T cells by glycolipids.
Anderson B, Teyton L, Bendelac A, Savage P
Molecules. 2013; 18(12):15662-88.
PMID: 24352021
PMC: 4018217.
DOI: 10.3390/molecules181215662.
Enhanced TCR footprint by a novel glycolipid increases NKT-dependent tumor protection.
Aspeslagh S, Nemcovic M, Pauwels N, Venken K, Wang J, Van Calenbergh S
J Immunol. 2013; 191(6):2916-25.
PMID: 23960235
PMC: 3817951.
DOI: 10.4049/jimmunol.1203134.
Carbohydrate-based vaccines with a glycolipid adjuvant for breast cancer.
Huang Y, Hung J, Cheung S, Lee H, Chu K, Li S
Proc Natl Acad Sci U S A. 2013; 110(7):2517-22.
PMID: 23355685
PMC: 3574961.
DOI: 10.1073/pnas.1222649110.
Raising the roof: the preferential pharmacological stimulation of Th1 and th2 responses mediated by NKT cells.
East J, Kennedy A, Webb T
Med Res Rev. 2012; 34(1):45-76.
PMID: 23239102
PMC: 4102678.
DOI: 10.1002/med.21276.
Towards multivalent CD1d ligands: synthesis and biological activity of homodimeric α-galactosyl ceramide analogues.
Jervis P, Moulis M, Jukes J, Ghadbane H, Cox L, Cerundolo V
Carbohydr Res. 2012; 356:152-62.
PMID: 22445102
PMC: 3413882.
DOI: 10.1016/j.carres.2012.02.034.